|
Proposed Asthma Inhaler Puts Patients at Risk
PR Newswire (press release) VIENNA, Va., Feb. 19, 2014 /PRNewswire-USNewswire/ — An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma … |
View full post on asthma – Google News